Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

  • Showing results for irritable bowel clostridium. Your search for irritable bowel Clostridum retrieved no results.
1.

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease.

Vaughn BP, Rank KM, Khoruts A.

Clin Gastroenterol Hepatol. 2018 Jul 25. pii: S1542-3565(18)30751-1. doi: 10.1016/j.cgh.2018.07.026. [Epub ahead of print] Review.

PMID:
30055267
2.

A systematic literature review of the effect of anthocyanins on gut microbiota populations.

Igwe EO, Charlton KE, Probst YC, Kent K, Netzel ME.

J Hum Nutr Diet. 2018 Jul 8. doi: 10.1111/jhn.12582. [Epub ahead of print] Review.

PMID:
29984532
3.

Standardized Preparation for Fecal Microbiota Transplantation in Pigs.

Hu J, Chen L, Tang Y, Xie C, Xu B, Shi M, Zheng W, Zhou S, Wang X, Liu L, Yan Y, Yang T, Niu Y, Hou Q, Xu X, Yan X.

Front Microbiol. 2018 Jun 19;9:1328. doi: 10.3389/fmicb.2018.01328. eCollection 2018. Review.

4.

The role of the microbiome for human health: from basic science to clinical applications.

Mohajeri MH, Brummer RJM, Rastall RA, Weersma RK, Harmsen HJM, Faas M, Eggersdorfer M.

Eur J Nutr. 2018 May 10. doi: 10.1007/s00394-018-1703-4. [Epub ahead of print]

PMID:
29748817
5.

Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.

Holleran G, Scaldaferri F, Ianiro G, Lopetuso L, Mc Namara D, Mele MC, Gasbarrini A, Cammarota G.

Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Review.

PMID:
29637938
6.

Status of Rifaximin: A Review of Characteristics, Uses and Analytical Methods.

Kogawa AC, Salgado HRN.

Crit Rev Anal Chem. 2018 Nov 2;48(6):459-466. doi: 10.1080/10408347.2018.1447355. Epub 2018 Mar 26. Review.

PMID:
29580065
7.

Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.

Yu LM, Zhao KJ, Wang SS, Wang X, Lu B.

World J Gastroenterol. 2018 Feb 28;24(8):894-904. doi: 10.3748/wjg.v24.i8.894.

8.

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Sun YY, Li M, Li YY, Li LX, Zhai WZ, Wang P, Yang XX, Gu X, Song LJ, Li Z, Zuo XL, Li YQ.

Sci Rep. 2018 Feb 14;8(1):2964. doi: 10.1038/s41598-018-21241-z.

9.

A Rare Cause of Recurrent Abdominal Pain and Diarrhea.

Allamneni C, Nelson G, Weber F.

Gastroenterology. 2018 Aug;155(2):e11-e12. doi: 10.1053/j.gastro.2017.12.035. Epub 2018 Feb 2. No abstract available.

PMID:
29408638
10.

Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6.

Zhao K, Yu L, Wang X, He Y, Lu B.

Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):216-223. doi: 10.1093/abbs/gmx138.

PMID:
29329362
11.

Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

Bassotti G, Macchioni L, Corazzi L, Marconi P, Fettucciari K.

Cell Mol Life Sci. 2018 Apr;75(7):1145-1149. doi: 10.1007/s00018-017-2736-1. Epub 2017 Dec 28.

PMID:
29285574
12.

Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.

Zhong W, Lu X, Shi H, Zhao G, Song Y, Wang Y, Zhang J, Jin Y, Wang S.

J Clin Gastroenterol. 2017 Nov 28. doi: 10.1097/MCG.0000000000000961. [Epub ahead of print]

PMID:
29210899
13.
14.

[Current research progress and thinking of fecal microbiota transplantation for the treatment of gastrointestinal disorders].

Li N, Tian H.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Oct 25;20(10):1104-1108. Chinese.

PMID:
29130220
15.

Increased Systemic Antibiotic Use and Clostridium difficile Infection Among Outpatients With Irritable Bowel Syndrome.

Longstreth GF, Chen Q, Wong C, Yao JF.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):974-976. doi: 10.1016/j.cgh.2017.11.004. Epub 2017 Nov 8. No abstract available.

PMID:
29128476
16.

[Faecal microbiota transplantation: indications in perspective].

van Beurden YH, Terveer EM, Keller JJ, Kuijper EJ, Mulder CJJ, Vandenbroucke-Grauls CMJE.

Ned Tijdschr Geneeskd. 2017;161:D1623. Review. Dutch.

PMID:
29076444
17.

Fecal microbiota transplantation: past, present and future perspectives.

Bibbò S, Ianiro G, Gasbarrini A, Cammarota G.

Minerva Gastroenterol Dietol. 2017 Dec;63(4):420-430. doi: 10.23736/S1121-421X.17.02374-1. Review.

PMID:
28927251
18.

[Faecal microbiota transplantation for the treatment of bowel disease].

Rode AA, Chehri M, Petersen AM, Bytzer P.

Ugeskr Laeger. 2017 Jul 31;179(31). pii: V03170218. Danish.

PMID:
28869008
19.

Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.

Wilkins T, Sequoia J.

Am Fam Physician. 2017 Aug 1;96(3):170-178. Review.

PMID:
28762696
20.

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.

Lopetuso LR, Petito V, Graziani C, Schiavoni E, Paroni Sterbini F, Poscia A, Gaetani E, Franceschi F, Cammarota G, Sanguinetti M, Masucci L, Scaldaferri F, Gasbarrini A.

Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7.

PMID:
28683448

Supplemental Content

Loading ...
Support Center